| 英文名称 |
中文名称 |
CAS号 |
操作 |
| BDP5290 |
BDP5290 |
1817698-21-7 |
详细
|
| Taltobulin |
N,BETA,BETA-三甲基-L-苯基丙氨酰基-N-[(1S,2E)-3-羧基-1-(1-甲基乙基)-2-丁烯基]-N,3-二甲基-L-缬氨酰胺 |
228266-40-8 |
详细
|
| Ala-Ala-Asn-PAB |
ALA-ALA-ASN-PAB |
2149584-00-7 |
详细
|
| JCP174 |
7-Amino-4-chloro-3-propoxy-isochromen-1-one |
126062-19-9 |
详细
|
| CL2 Linker |
CL2 Linker |
2270986-66-6 |
详细
|
| MMAE-SMCC |
MMAE-SMCC |
2021179-11-1 |
详细
|
| AMAS |
马来酰亚胺基乙酸琥珀酰亚胺酯 |
55750-61-3 |
详细
|
| MC-Val-Ala-PAB-PNP |
Mc-Val-Ala-PAB-PNP |
1639939-40-4 |
详细
|
| Fluzoparib |
氟唑帕利 |
1358715-18-0 |
详细
|
| GSK963 |
GSK963(S构型) |
2049868-46-2 |
详细
|
| ML-226 |
ML-226 |
2055172-43-3 |
详细
|
| BRD6688 |
BRD6688 |
1404562-17-9 |
详细
|
| SGA360 |
SGA360 |
680611-86-3 |
详细
|
| SW155246 |
4-Chloro-N-(4-hydroxy-1-naphthalenyl)-3-nitro-benzenesulfonamide |
420092-79-1 |
详细
|
| Epiblastin A |
Epiblastin A |
16470-02-3 |
详细
|
| GW280264X |
((S)-5-((2R,3S)-3-(N-羟基甲酰胺基)-2-异丁基六氨基)-2-氧代-6-(噻唑-2-基氨基)己基)氨基甲酸苄酯 |
866924-39-2 |
详细
|
| SAR405 R enantiomer |
SAR405 R enantiomer |
1946010-79-2 |
详细
|
| NVS-ZP7-4 |
NVS-ZP7-4 |
2349367-89-9 |
详细
|
| Salirasib |
法尼基硫代水杨酸 |
162520-00-5 |
详细
|
| BGC201531 |
BGC-20-1531 |
1186532-61-5 |
详细
|
| DD1 |
化合物DD1 |
187585-11-1 |
详细
|
| SC-57461A |
N -甲基- N -[3 - [4 - (苯甲基)苯氧基]丙基Β-丙氨酸盐酸盐 |
423169-68-0 |
详细
|
| CC-90001 |
CC90001 |
1403859-14-2 |
详细
|
| LYS01 |
LYS05 |
1391426-22-4 |
详细
|
| FLTX1 |
2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro- |
1481401-71-1 |
详细
|
| Nemorubicin |
奈莫柔比星 |
108852-90-0 |
详细
|
| AkaLumine |
AKA LUMINE |
1176235-08-7 |
详细
|
| TLR7/8-IN-1 |
TLR7/8-IN-1 |
2205095-75-4 |
详细
|
| Eribulin mesylate |
甲磺酸艾日布林 |
441045-17-6 |
详细
|
| SEMBL |
SEMBL |
1443448-82-5 |
详细
|
| IMM-H007 |
化合物IMM-H007 |
1221412-23-2 |
详细
|
| NPD8733 |
化合物NPD8733 |
696655-62-6 |
详细
|
| Valnivudine |
Valnivudine |
956483-03-7 |
详细
|
| squarunkinA |
化合物SQUARUNKINA |
2101958-02-3 |
详细
|
| RG7834 |
RO 7020322 |
2072057-17-9 |
详细
|
| KLH45 |
KLH45 |
1632236-44-2 |
详细
|
| AH-3960 |
化合物AH-3960 |
862907-48-0 |
详细
|
| Desketoraloxifene |
Benzo[b]thiophene-6-ol, 2-(4-hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenyl]- |
216570-81-9 |
详细
|
| GSK864 |
1816331-66-4 |
1816331-66-4 |
详细
|
| Takeda103A |
Takeda103A |
865609-72-9 |
详细
|
| RH01687 |
RH01687 |
302901-13-9 |
详细
|
| GNE-140 racemate |
GNE140 racemate |
1802977-61-2 |
详细
|
| Deferitrin |
地夫立群 |
239101-33-8 |
详细
|
| PF-06446846 hydrochloride |
PF-06446846 |
1632250-50-0 |
详细
|
| Soporidine |
化合物SOPORIDINE |
1060376-43-3 |
详细
|
| Preq1 Dihydrochloride |
Pre-queuosine1 dihydrochloride |
86694-45-3 |
详细
|
| MTI-31 |
MTI-31 |
1567915-38-1 |
详细
|
| MT 63-78 |
5-{2',6'-dihydroxy-[1,1'-biphenyl]-4-yl}-1H-indole-3-carbonitrile |
1179347-65-9 |
详细
|
| ML349 |
APT-2抑制剂 |
890819-86-0 |
详细
|
| NCGC00262650 |
NCGC00262650 |
344359-25-7 |
详细
|
| RP-6685 |
化合物RP-6685 |
2832047-80-8 |
详细
|
| Rineterkib |
ERK-IN-1 (COMPOUND B) |
1715025-32-3 |
详细
|
| Povorcitinib |
INCB54707 |
1637677-22-5 |
详细
|
| BRM/BRG1 ATP Inhibitor-1 |
1-(3-(DIFLUOROMETHYL)ISOTHIAZOL-5-YL)-3-(2-FLUORO-5-(HYDROXYMETHYL)PYRIDIN-4-YL)UREA |
2270879-17-7 |
详细
|
| Upacicalcet |
乌帕西卡塞 |
1333218-50-0 |
详细
|
| PKC-iota inhibitor 1 |
2-氨基-5-(3-(哌嗪-1-基)苯基)-N-(吡啶-4-基)烟酰胺 |
2328094-11-5 |
详细
|
| VTP-27999 |
N-[2-[(R)-(3-氯苯基)[(3R)-1-[[[(2S)-2-(甲基氨基)-3-[(3R)-四氢-2H-吡喃-3-基]丙基]氨基]羰基]-3-哌啶基]甲氧基]乙基]氨基甲酸甲酯 |
942142-51-0 |
详细
|
| C188-9 |
432001-19-9 |
432001-19-9 |
详细
|
| APS-2-79 |
2002381-25-9 |
2002381-25-9 |
详细
|
| INH154 |
化合物INH154 |
1587705-63-2 |
详细
|
| NRC-2694 |
936446-61-6 |
936446-61-6 |
详细
|
| Baxdrostat |
BAXDROSTAT |
1428652-17-8 |
详细
|
| Amcenestrant |
SAR-439859 |
2114339-57-8 |
详细
|
| Sovilnesib |
Sovilnesib |
2410796-79-9 |
详细
|
| GSK 366 |
GSK366) |
1953157-39-5 |
详细
|
| NVP-DKY709 |
NVP-DKY709 |
2291360-73-9 |
详细
|
| TY-51469 |
CBRCULCCRGSSLB-UHFFFAOYSA-N |
603987-59-3 |
详细
|
| VAF347 |
2-PYRIMIDINAMINE, 4-(3-CHLOROPHENYL)-N-[4-(TRIFLUOROMETHYL)PHENYL]- |
574759-62-9 |
详细
|
| Oritinib |
化合物ORITINIB |
2035089-28-0 |
详细
|
| Sunvozertinib |
DZD 9008 |
2370013-12-8 |
详细
|
| Linaprazan glurate |
Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester |
1228559-81-6 |
详细
|
| GJ103 |
GJ103 游离 |
1459687-89-8 |
详细
|
| AGI-43192 |
化合物AGI-43192 |
2377491-54-6 |
详细
|
| BI605906 |
化合物 T14567 |
960293-88-3 |
详细
|
| GPR84 antagonist 8 |
GPR84 ANTAGONIST 8 |
1445846-30-9 |
详细
|
| Eciruciclib |
化合物 ECIRUCICLIB |
1868086-40-1 |
详细
|
| Baloxavir |
巴洛沙韦 |
1985605-59-1 |
详细
|
| MC-Gly-Gly-Phe-Gly |
Mc-GGFG-OH |
2413428-36-9 |
详细
|
| Simmiparib |
SIMMIPARIB |
1551355-46-4 |
详细
|
| Dilmapimod |
444606-18-2 |
444606-18-2 |
详细
|
| Nitroflurbiprofen |
158836-71-6 |
158836-71-6 |
详细
|
| JNJ-42165279 |
N-(4-氯-3-吡啶基)-4-[(2,2-二氟-1,3-苯并二恶茂-5-基)甲基]-1-哌嗪甲酰胺 |
1346528-50-4 |
详细
|
| GZD856 |
GZD856 |
1257628-64-0 |
详细
|
| ARS-1630 |
ARS-1630 |
1698055-86-5 |
详细
|
| GSK-2793660 |
2H-Pyran-4-carboxamide, 4-amino-N-[(1S,2E)-4-(2,3-dihydro-1H-indol-1-yl)-1-ethyl-4-oxo-2-buten-1-yl]tetrahydro- |
1613458-70-0 |
详细
|
| AGI-41998 |
化合物 AGI-41998 |
2377492-26-5 |
详细
|
| PD158780 |
N4-(3-溴苯基)-N6-甲基-吡啶并[3,4-D]嘧啶-4,6-二胺 |
171179-06-9 |
详细
|
| Befotertinib |
BEFOTERTINIB |
1835667-63-4 |
详细
|
| MLN-4760 |
MLN-4760 |
305335-31-3 |
详细
|
| (αR,8aS)-GSK1614343 |
化合物 T27451 |
1092476-84-0 |
详细
|
| HBX 19818 |
9-氯-5,6,7,8-四氢-N-[3-[甲基(苄基)氨基]丙基]-2-吖啶甲酰胺 |
1426944-49-1 |
详细
|
| Lasalocid sodium |
拉沙里菌素 |
25999-20-6 |
详细
|
| NU1025 |
NU1025 |
90417-38-2 |
详细
|
| Emavusertib |
4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- |
1801344-14-8 |
详细
|
| IND24 |
4-([1,1'-biphenyl]-4-yl)-N-(6-methylpyridin-2-yl)thiazol-2-amine |
1426047-44-0 |
详细
|
| EBOV/MARV-IN-1 |
VUN65671 |
2479465-67-1 |
详细
|
| Povorcitinib phosphate |
POVORCITINIB磷酸盐 |
1637677-33-8 |
详细
|
| CUR61414 |
CUR 61414 |
334998-36-6 |
详细
|
| BRD0705 |
BRD0705 |
2056261-41-5 |
详细
|
| Ginsenoside C-K |
20(S)-人参皂苷 C-K |
39262-14-1 |
详细
|